The EviDynamics is the leading-edge forum focusing on the advancement and integration of Artificial Intelligence within the domains of Real World Evidence and Real World Data.
Gathering RWE Professionals, AI specialists and decision makers from around the globe, this conference is dedicated to fostering knowledge exchange, innovation and providing concrete and actionable insights.
Date: 29-30 Oct, 2024
Venue: Medicon Valley Alliance, Arne Jacobsens Allé 13, 2300 Copenhagen S, Denmark – HUB3
As a member of Medicon Valley Alliance you can register to this event with a 20% discount. Contact David Munis Zepernick, dz@mva.org, to receive the discount code.
Keynote speakers
 |
Thirupathi Pattipaka Global Director of DataScience & AI / Novartis / Basel, SwitzerlandAs Global Director of Evidence Generation DataScience & AI, Thirupathi has spearheaded a transformative approach to generate RWE by harnessing the power of Artificial Intelligence (AI) and scalable platforms.He is leading a team to reduce the RWE execution time through the implementation of GenAI applications and has fostered a high-performing team of data scientists, engineers, and researchers who are building cutting-edge AI products that leverage RWD to improve efficiencies across the drug development lifecycle including clinical trial designs.Thirupathi has also led the development of a secure and scalable data science platform, further accelerating the analytics process. |
 |
Dr Jessica Santos Global Compliance and Quality Director / Oracle Life Sciences / Cambridge, UKDr Jessica Santos is the Global Compliance and Quality Director and Data Protection Officer in Oracle Life Sciences, provides consulting and research to communicate the value and potential for products and services that fall under healthcare regulation and legislation. Jessica is providing oversight and support across global offices in regulation, ethics and compliance, and responsible for maintaining, anticipating and coordinating all activities regarding compliance, privacy, ethics and quality framework on RWR (Real World Research) and MR (Market Research).Jessica is also an experienced statistician, analyst and methodologist. She gained her reputation through her publications and professional committee work in the industry. Jessica is a frequent speaker and contributor in major conferences. She has a PhD in Social Science and MRS fellowship.Jessica is a member of BHBIA and EphMRA code of Ethics Committee, UK Research Ethics Committee, reviewer and chair of ISPOR Code of Conduct Committee. |
 |
Magnus Nydén Head of Innovation / AstraZeneca / Gothenburg, SwedenMagnus Nydén is the Head of Innovation at AstraZeneca, where he leads the Digital Science and AI-, the Lean- and the Innovation- and Business Development teams within Pharmaceutical Technology & Development. With a career spanning both academia and industry, Magnus brings expertise that allows him to act at the interfaces between chemistry, physics, biology, material science, spectroscopy and applied mathematics, including artificial intelligence.Magnus began his academic career after completing his MSc and PhD in Physical Chemistry and Material Science from Lund University, specializing in Nuclear Magnetic Resonance. In 1999, he joined Chalmers University of Technology as an assistant professor, rising to the position of full professor by 2008. His academic contributions include supervising 30 PhD students and 20 postdoctoral researchers, with a focus on spectroscopy, material science and applied mathematics.In 2012, Magnus transitioned to the University of South Australia as an institute director, where he led various large-scale research initiatives. He continued to build on his leadership experience at UCL as head of school in 2015, before moving to AkzoNobel as the global chief scientist. In 2019, he took on the role of CTO and public policy director at Liquid Wind in Sweden, focusing on sustainable energy solutions.Returning to academia, Magnus served as the executive dean of science and engineering at Macquarie University in Sydney. His tenure was marked by significant advancements in education, scientific research and innovation, in particular in using AI for advancing university offering to students with low grades. The intention was to mitigate the negative effects seen in the world inequality report where children in high income families on average have lower grades than students in families with high income.At AstraZeneca, Magnus is at the forefront of integrating AI and digital science to transform pharmaceutical development. He leads a program aimed at creating a holistic digital twin of AstraZeneca’s business, employing various AI methods, including Generative AI. This initiative seeks to optimize the development process, reduce costs, lower the carbon footprint, and enhance productivity, ultimately improving the accessibility and affordability of medicines for our patients.Magnus’s professional journey is complemented by his passion for the ocean and racket sports. He is a former Swedish national champion in table tennis, demonstrating his dedication and competitive spirit. |
For the latest program and list of all speakers visit the event page.
| Organized by | In collaboration with |
 |
 |